Sort by
Refine Your Search
-
in the following five thematic areas: 1. Theme 1 (“Nowcasting”): Hybrid Physics-AI for Short-term Weather and Hydrologic Prediction Skillful predictions of weather and hydrology in the short-term (few
-
. While candidates in all areas will be considered, priority will be given to the following areas: Embodied AI Software, Systems, and Security AI and Life Sciences Socially Responsive AI Appointments will
-
revolutionize the healthcare penetration testing marketplace by shifting the focus from compliance-based checklists to understanding how gracefully a hospital system fails and recovers under attack. The platforms
-
, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral support. In addition, Ironwood has been a pioneer in the development of LINZESS
-
, neoantigens, cytokines, and antibodies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Bristol Myers Squibb, Duality
-
examine how individual differences in these processes confer risk or resilience to mental health problems. As part of the Center for Cognitive and Brain Health, there is ample opportunity for collaboration
-
fellowship legacy project. Other Opportunities Fellows will also have the opportunity to tailor their experience by engaging in optional cross-functional projects or short-term rotations across key departments
-
, or health-related field by the appointment start date. A record of outstanding research during the Ph.D., as evidenced by publications, grants, software outputs, and other scholarly measures of impact
-
, disability status, or any other characteristic protected by applicable law. Compensation Grade/Pay Type: 108S Expected Hiring Range: $60,315.00 - $85,192.50 With the pay range(s) shown above, the starting
-
. About Eidos and BridgeBio Pharma Inc. BridgeBio Pharma, Inc. (BridgeBio/BBIO) is a biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who